On March 14, the Centers for Medicare and Medicaid Services (CMS) published tools and guidance for states on how to monitor and evaluate 1115 waivers that implement work requirements, require monthly premiums, implement premium assistance programs, waive retroactive eligibility, or implement non-eligibility periods for failing to meet requirements. Additionally, CMS published monitoring and evaluation guidance and tools for states that are implementing substance use disorder 1115 waivers, such as those waiving the Medicaid Institution for Mental Disease exclusion. States are required to monitor and evaluate 1115 demonstration waivers. These new tools are intended to support states in meeting these evaluation requirements.
For more information visit the McDermottPlus Payment Innovation Resource Center or contact Katie Weider at 212-547-5433 or email@example.com.